Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson | 39 | 1 | 4 | 0 | €147.62 | €195.31 | 32.303% |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.64 | €10.54 | 189.813% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €9.45 | €10.00 | 5.820% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.90 | €4.63 | 59.291% |
| Roche Holding AG ADR | 2 | 2 | 0 | 0 | €37.10 | €38.00 | 2.426% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €26.11 | €38.62 | 47.925% |
| Novo Nordisk A/S ADR | 20 | 1 | 1 | 0 | €118.00 | €144.02 | 22.050% |
| Twist Bioscience Corp | 11 | 0 | 2 | 0 | €55.50 | €53.41 | -3.774% |
| Cocrystal Pharma Inc. | 7 | 0 | 0 | 0 | €2.00 | €9.25 | 362.700% |
| Celldex Therapeutics | 16 | 1 | 1 | 0 | €41.20 | €61.99 | 50.457% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €105.85 | - | - |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.94 | €6.45 | 231.924% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €47.60 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €5.65 | - | - |
| Icon plc | 23 | 0 | 2 | 0 | €288.80 | €326.56 | 13.074% |
| Teva Pharmaceutical Industries Ltd ADR | 17 | 0 | 3 | 0 | €15.70 | €18.95 | 20.697% |
| Immunic Inc. | 6 | 3 | 1 | 0 | €1.31 | €6.52 | 399.632% |
| Amgen Inc. | 25 | 0 | 2 | 0 | €309.35 | €304.65 | -1.520% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €4.88 | - | - |
| Biogen Inc. | 52 | 1 | 4 | 0 | €198.10 | €292.88 | 47.843% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.61 | - | - |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €3.00 | €4.00 | 33.333% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €51.50 | €50.00 | -2.913% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Prothena Corp. plc | 11 | 0 | 0 | 0 | €22.80 | €79.47 | 248.534% |